- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01988389
Effect of Apples on cardioVascular Risk And Gut Health (AVAG)
March 6, 2015 updated by: Julie Lovegrove, University of Reading
Effect of Apples Consumption on Blood Lipid Levels,Vascular Function and Gut Health in Moderate Hypercholesterolemic Subjects
There is now considerable scientific evidence that a diet rich in fruits and vegetables could improve human health.
Apples are among the most frequently consumed fruits in the world.
Epidemiological studies have linked frequent apple consumption with several health benefits including a reduced risk of cardiovascular disease.
Apples are an important source of polyphenols and fiber and their beneficial effects could be attributed to this content; however, their impact on our health is not clear.
Although, there are some studies that have reported cholesterol lowering effects the results are inconsistent.
Furthermore, few studies have explored the impact on vascular function and gut microbiota.
The objective of the current study is to assess whether a regular apple consumption, reduces total cholesterol levels, improves vascular function and gut microbiota profile in mildly hypercholesterolemic subjects compared with a control, sugar matched commercial clear apple juice squash.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
40
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Berkshire
-
Reading, Berkshire, United Kingdom, RG6 6AP
- Department of Food and Nutritional Sciences, University of Reading
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
23 years to 69 years (ADULT, OLDER_ADULT)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Mildly hypercholesterolemic: TC>5.2 and <7.9 mmol/L
- BMI: 20-35
- Age: 23-69
- Normal liver and kidney function
Exclusion Criteria:
- Drug treatment for hyperlipidaemia, hypertension, inflammation and hypercoagulation.
- Vegetarians.
- Smoking.
- History of alcohol misuse.
- History of food allergy (e.g. apples, sulphites).
- Taking antibiotics for the previous 3 months.
- Taking phytochemical, antioxidant, fish oil supplements, or prebiotic/probiotic preparations unless willing to stop for the study period and after a 4 week wash out period (8 weeks for fish oil).
- Females who are pregnant, lactating, or if of reproductive age and not using a reliable form of contraception (including abstinence).
- Medical history of cardiovascular disease including coronary heart disease (angina and heart attack) and stroke (in the past 12 months).
- Family history of cardiovascular disease (their father or brother was under 55 or their mother or sister was under 65 when they were diagnosed with cardiovascular disease).
- Diabetes mellitus.
- Kidney, liver, pancreas or gastrointestinal diseases.
- Hematologic disorders (i.e. anaemia; men:haemoglobin<13.8g/dl (8.56mmol/L) and women<12.1 g/dl (5.51mmol/L)).
- Planning a weight reducing regime.
- Parallel participation in another dietary intervention study.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: PREVENTION
- Allocation: RANDOMIZED
- Interventional Model: CROSSOVER
- Masking: NONE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
EXPERIMENTAL: whole apples
Subjects are asked to consume 2 apples a day for 8 weeks in addition to their habitual diet
|
|
OTHER: apple juice squash
Subjects are asked to consume 100 ml of apple juice squash (recommended dilution with water up to 500 ml) for 8 weeks in addition to their habitual diet.
The apple juice is used as a sugar matched control.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Changes in blood lipid levels
Time Frame: Baseline and assessment at 8 weeks for each intervention arm including a 4 week wash out period.
|
Baseline and assessment at 8 weeks for each intervention arm including a 4 week wash out period.
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Evaluation of endothelial function by using laser doppler iontophoresis (LDI)
Time Frame: Baseline and assessment at 8 weeks for each intervention arm.
|
Baseline and assessment at 8 weeks for each intervention arm.
|
|
Changes in vascular stiffness by pulse wave analysis (PWA)
Time Frame: Baseline and assessment at 8 weeks for each intervention arm
|
Baseline and assessment at 8 weeks for each intervention arm
|
|
Changes in faecal bacterial population
Time Frame: Baseline and assessment at 8 weeks for each intervention arm
|
Baseline and assessment at 8 weeks for each intervention arm
|
|
Ambulatory blood pressure
Time Frame: Baseline and assessment at 8 weeks for each intervention arm
|
Blood pressure will be recorded for 30 minutes at baseline and at 8 weeks for each intervention arm
|
Baseline and assessment at 8 weeks for each intervention arm
|
Changes in inflammatory, endothelial function and oxidative stress markers
Time Frame: Baseline and assessment at 8 weeks for each intervention arm
|
Baseline and assessment at 8 weeks for each intervention arm
|
|
Changes in insulin resistance and gut hormones
Time Frame: Baseline and assessment at 8 weeks for each intervention arm
|
Baseline and assessment at 8 weeks for each intervention arm
|
|
Metabolomic analysis for the determination of the low molecular weight metabolite profiles in the biological fluids (blood, urine and faecal sample).
Time Frame: Baseline and assessment at 8 weeks for each intervention arm
|
Baseline and assessment at 8 weeks for each intervention arm
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Investigators
- Principal Investigator: Julie A Lovegrove, BSc, PhD, RNutr, University of Reading
- Principal Investigator: Kieran Tuohy, Dr, FEM-IASMA Research and Innovation centre
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
September 1, 2013
Primary Completion (ACTUAL)
October 1, 2014
Study Completion (ACTUAL)
November 1, 2014
Study Registration Dates
First Submitted
October 10, 2013
First Submitted That Met QC Criteria
November 11, 2013
First Posted (ESTIMATE)
November 20, 2013
Study Record Updates
Last Update Posted (ESTIMATE)
March 9, 2015
Last Update Submitted That Met QC Criteria
March 6, 2015
Last Verified
March 1, 2015
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 13/22
- University of Reading (Other Identifier: Reading University)
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Mild Hypercholesterolemia
-
Danone JapanCompletedHealthy | Mild HypercholesterolemiaJapan
-
National Medical Research Center for Therapy and...Moscow State University of Medicine and DentistryRecruitingMedication Adherence | Adherence, Medication | Treatment Adherence | Familial Hypercholesterolemia | Motivational Interviewing | Adherence, Patient | Treatment Adherence and Compliance | Patient Compliance | Adherence | Hypercholesterolemia, Familial | Patient Adherence | Hypercholesterolemia, Autosomal Dominant and other conditionsRussian Federation
-
Direct PlantesUnknownHYPERCHOLESTEROLEMIAFrance
-
Chong Kun Dang PharmaceuticalRecruitingPrimary HypercholesterolemiaKorea, Republic of
-
Addpharma Inc.CompletedPrimary HypercholesterolemiaKorea, Republic of
-
JW PharmaceuticalCompletedPrimary HypercholesterolemiaKorea, Republic of
-
Hanmi Pharmaceutical Company LimitedCompletedPrimary HypercholesterolemiaKorea, Republic of
-
Provident Clinical ResearchGlaxoSmithKlineUnknownPrimary HypercholesterolemiaUnited States
-
Organon and CoCompletedPrimary Hypercholesterolemia | Homozygous Familial Hypercholesterolemia
-
Boryung Pharmaceutical Co., LtdRecruitingPrimary HypercholesterolemiaKorea, Republic of
Clinical Trials on whole apples (WA)
-
PepsiCo Global R&DCompletedGlycemic ResponseUnited States
-
University of NottinghamKing's College LondonCompletedGastrointestinal SymptomsUnited Kingdom
-
University of GuelphAgriculture and Agri-Food Canada; Ontario Ministry of Agriculture, Food and... and other collaboratorsCompletedInflammation | Hyperlipidemias | Dysbiosis | Obesity, AbdominalCanada
-
San Diego State UniversityCompleted
-
Maastricht University Medical CenterNot yet recruitingMicrobial Colonization | Enzyme Overdose
-
Queen's University, BelfastCompletedCardiovascular DiseaseUnited Kingdom
-
Translational Research Center for Medical Innovation...Kagoshima University; Nippon Medical SchoolCompleted
-
University of CopenhagenCentral Jutland Regional Hospital; Technical University of DenmarkCompletedCardiovascular DiseasesDenmark
-
VisionCare, Inc.TerminatedAge Related Macular DegenerationIreland, Spain
-
Translational Research Center for Medical Innovation...Moji Medical Center, Kyusyu Rosai HospitalCompleted